Fadogia agrestis became one of the most searched testosterone supplements in the English-speaking world after prominent health podcasters cited it in 2022 and 2023. The research that generated that attention comes almost entirely from rat studies published by a small number of researchers in Nigeria. No randomized controlled trial in healthy humans has confirmed any of those findings.
That gap matters for men over 40 trying to make an informed decision. The same studies that show testosterone increases in rodents also document testicular histological changes and elevated liver markers at higher doses. The supplement industry extracted the promising numbers from those papers and left the safety data out of the marketing copy. Men deserve to see both halves of the evidence.
In this article:
- What is Fadogia agrestis
- How it became popular
- What the animal research shows
- The toxicity findings you won't see in ads
- The human evidence gap
- How it's supposed to work
- Dosage and product quality problems
- How fadogia compares to supplements with actual human data
- Who should consider it and who shouldn't
- FAQ
Key Takeaways
- Fadogia agrestis is a West African shrub with a long history in traditional medicine; it reached the Western supplement market after podcast mentions in 2022-2023
- Rat studies show dose-dependent testosterone increases of 30-100%, primarily via LH stimulation, but the same research documents testicular cell damage at higher doses
- As of 2026, no published randomized controlled trial in humans has confirmed testosterone-raising effects
- No established human equivalent dose exists; products selling 400-600 mg/day are extrapolating from animal data without pharmacokinetic validation
- Tongkat ali, ashwagandha, and shilajit all have published human RCTs; fadogia agrestis does not
- Men who want to optimize testosterone have better-evidenced options available before considering an unvalidated compound
What Is Fadogia Agrestis
Fadogia agrestis is a shrub native to West and Central Africa, particularly Nigeria and surrounding countries, where it grows in savanna and woodland habitats. Traditional Nigerian medicine used the stem extract as an aphrodisiac and general male tonic. The plant contains several classes of bioactive compounds including steroidal saponins, alkaloids, anthraquinones, and flavonoids. The saponins are considered the primary pharmacologically active fraction.
The plant is not related to any common food crop. It was essentially unknown in Western supplement markets before 2022. Traditional use does not validate safety or efficacy in the way clinical trials do, but it does suggest the plant has biological activity worth studying. The absence of well-documented traditional dosing protocols is a separate concern: most traditional preparations used boiled aqueous extracts under supervision of traditional practitioners, not the standardized dry extracts sold in capsule form today.
How It Became Popular
The supplement gained mainstream attention in the West after podcasters with large audiences discussed it as a potential testosterone-boosting compound in 2022. That discussion referenced the Nigerian animal studies and framed the compound as an emerging option for men wanting to raise luteinizing hormone (LH) and testosterone naturally.
The timing aligned with rising consumer interest in testosterone optimization and growing skepticism about pharmaceutical TRT for otherwise healthy men. Supplement manufacturers moved quickly. Within months, fadogia agrestis products appeared on major e-commerce platforms, often stacked with tongkat ali, often at price points between $30 and $60 per month. Several products cited the rat study findings directly in their marketing.
The problem with this trajectory is structural: animal data suggested a promising mechanism, podcast discussion created consumer demand, and products hit shelves years before human safety and efficacy data existed. This pattern has repeated across many supplements. For men over 40 making real decisions about their health, the sequence matters.
What the Animal Research Shows
The scientific foundation for fadogia agrestis in testosterone optimization rests on a handful of studies, almost all from the same research group at the University of Ilorin in Nigeria.
The most frequently cited study, published in the Journal of Ethnopharmacology in 2008 by Yakubu MT et al., administered aqueous stem extracts to male rats at three doses (18, 36, and 72 mg/kg body weight) for five days. Serum testosterone rose in a dose-dependent manner: 18 mg/kg produced roughly a 30% increase; 36 mg/kg produced approximately 60%; 72 mg/kg produced around 100% above controls. LH levels showed parallel increases, suggesting a hypothalamic-pituitary mechanism rather than direct testicular stimulation.
Earlier work from the same group published in Asian Journal of Andrology (2005) studied aphrodisiac parameters, measuring mount latency, intromission frequency, and ejaculation frequency in rats. The extract produced significant improvements at moderate doses compared to controls. Testosterone and LH were elevated in those animals as well.
These are real findings from peer-reviewed publications. They are also rat studies. The pharmacokinetics of plant-derived saponins differ substantially between rodents and humans, and rat studies routinely overpredict effects in human trials across pharmacology.
| Study | Model | Dose | Key Finding |
|---|---|---|---|
| Yakubu et al., J Ethnopharmacol, 2008 | Male albino rats | 18-72 mg/kg | Dose-dependent T and LH increases |
| Yakubu et al., Asian J Androl, 2005 | Male albino rats | 18-50 mg/kg | Aphrodisiac behavior, elevated T |
| Multiple follow-up studies | Rats | Various | Mixed toxicity findings at higher doses |
The Toxicity Findings You Won't See in Ads
The same body of research that shows testosterone increases in rats also documents significant safety concerns at higher doses. Histological examination of testicular tissue from rats receiving higher doses showed structural changes to seminiferous tubules and Leydig cells — the cells responsible for producing testosterone. Elevated serum markers of liver and kidney stress appeared in some high-dose groups.
This creates a narrow apparent therapeutic window in the animal model: the doses that raise testosterone most aggressively are close to the doses that damage the tissue responsible for producing testosterone. That is a serious concern that does not appear on most supplement labels or in most podcast discussions about the compound.
Additional toxicity concerns from the literature:
Hepatotoxicity signals: Elevated liver enzymes (ALT, AST) at higher doses in multiple rat studies. The magnitude is dose-dependent, but the direction is consistent.
Kidney markers: Blood urea nitrogen and creatinine elevations at higher doses in some studies, suggesting renal stress.
Testicular histology: Seminiferous tubule damage and interstitial cell changes are documented at 72 mg/kg and above in the Yakubu research. These are not benign findings — they indicate potential long-term impairment of testosterone production itself.
None of this means fadogia agrestis is certainly toxic in humans at available doses. It means the safety profile is uncharacterized in humans, and the animal data flags real concerns. Men considering the supplement deserve to weigh this.
The Human Evidence Gap
As of mid-2026, no published randomized controlled trial has examined fadogia agrestis in humans for testosterone outcomes. No phase I safety trial has established human pharmacokinetic data. No peer-reviewed study has determined what dose in humans produces the blood concentrations seen in the animal studies.
This is not a minor gap. For comparison:
- Tongkat ali has multiple published human RCTs, including a 2012 pilot study in the Journal of the International Society of Sports Nutrition and a 2013 study in Andrologia showing free testosterone and DHEAS increases in stressed adults
- Ashwagandha has at least four published human RCTs showing effects on testosterone and cortisol, including a rigorous 2019 study in Medicine
- Shilajit has two human RCTs showing testosterone increases in healthy men
Fadogia agrestis has zero. The entire case for using it rests on rodent pharmacology and traditional use claims. Demanding human data before supplementation is not excessive caution — it is the minimum standard of evidence.
How It's Supposed to Work
The proposed mechanism runs through the hypothalamic-pituitary-gonadal (HPG) axis. Saponins in fadogia agrestis are hypothesized to stimulate gonadotropin-releasing hormone (GnRH) release from the hypothalamus or to act at the pituitary level to increase LH secretion. Rising LH then signals Leydig cells in the testes to produce more testosterone.
This is a biologically plausible pathway. Other compounds with human evidence operate through similar mechanisms. Tongkat ali's quassinoids appear to reduce sex hormone-binding globulin and support LH. Some flavonoids interact with GnRH receptors in vitro.
The challenge is that plausible mechanisms require human confirmation. Many compounds with clear mechanisms in animal models and cell studies produce no measurable hormonal effect in clinical trials. The HPG axis involves extensive negative-feedback regulation, and introducing a plant extract into that system can produce unexpected results in the other direction.
If your testosterone is low, the cause matters as much as any treatment you consider. Getting a full hormone panel that includes total T, free T, LH, FSH, SHBG, and estradiol will tell you whether your axis is functioning properly. The free testosterone calculator using the Vermeulen formula translates your lab values into the free testosterone fraction that actually drives physiological effects. If high SHBG is binding up your free testosterone, an LH-stimulating supplement doesn't address the problem.
Dosage and Product Quality Problems
Products on the market sell fadogia agrestis at doses of 400-600 mg/day. This figure is not derived from human pharmacokinetic data. It is roughly extrapolated from the rat studies using body surface area conversion methods that are known to overestimate human equivalent doses for many compounds.
A 72 mg/kg dose in a 250-gram rat would correspond to roughly 18 mg daily for a 250-pound (113 kg) man using direct body weight scaling — far below the 400-600 mg products typically sell. Body surface area scaling gives a higher number but still doesn't validate the commercial doses since no human absorption data exists.
Extract standardization is an additional problem. Products don't standardize to a specific saponin percentage or a validated marker compound. Different manufacturers produce different chemical profiles. The rat studies used aqueous (water-based) extracts. Many commercial products use alcoholic or CO2 extractions, which yield different compound ratios. You cannot directly compare the two.
If you insist on trying fadogia agrestis despite the evidence gaps, starting at the lower end of available commercial doses and cycling use (8 weeks on, 4 weeks off) is more defensible than continuous high-dose use. Baseline and follow-up labs are not optional here given the toxicity signals in animal data.
How Fadogia Compares to Supplements with Actual Human Data
The testosterone supplement category contains many compounds. Several have cleared the bar of human clinical trials.
Tongkat ali (Eurycoma longifolia): Multiple human RCTs confirm testosterone and free testosterone increases in stressed, hypogonadal, and aging men. A 2013 study in Andrologia found a 37% increase in free testosterone in men with late-onset hypogonadism after four weeks of 200 mg daily. Tongkat ali also has established safety data in humans. The evidence base is incomparably stronger than fadogia's.
Ashwagandha (KSM-66 extract): A 2019 RCT in Medicine found 225 mg twice daily increased testosterone by 14.7% over 8 weeks in healthy men. Cortisol reduction appears to be the primary mechanism. Multiple replication studies confirm the direction of effect.
Shilajit: A 2016 human study found 250 mg twice daily of purified shilajit raised free testosterone by 19% and total testosterone by 20% over 90 days in healthy men aged 45-55.
Zinc: In zinc-deficient men, supplementation at 25-30 mg/day restores testosterone toward normal ranges. This has the broadest human evidence base of any testosterone-supporting mineral, and zinc deficiency is common in men over 40.
None of these compounds are magic. Each works within specific contexts and for specific mechanisms. But they share something fadogia does not: evidence that they do something measurable in a human being.
Who Should Consider It and Who Shouldn't
Potentially reasonable to consider if:
- You have exhausted better-evidenced options and confirmed they don't apply to your situation
- You understand the human evidence gap and accept the uncertainty
- You plan to get baseline labs (testosterone panel, liver function, kidney function) and repeat them after 8 weeks
- You are not taking any medications that could interact with a plant extract affecting liver enzymes
Not appropriate if:
- You haven't had testosterone levels checked (you're guessing at a problem you haven't confirmed exists)
- You have any liver or kidney condition
- You are on prescription medications (hepatic enzyme induction from plant compounds can alter drug metabolism)
- You're looking for a first-line testosterone optimization strategy when options with human evidence haven't been tried
- You are cycling it long-term without lab monitoring
The honest answer for most men over 40 is that the protocol should start elsewhere. Getting your testosterone levels checked tells you whether you have a problem and what kind. That answer shapes everything that follows. If total testosterone is low-normal with low free T and high SHBG, the intervention looks completely different than low total T with normal SHBG. A fadogia agrestis capsule doesn't diagnose that. Blood work does.
If after reviewing your labs and trialing better-evidenced compounds you still want to explore fadogia agrestis, run it at the lowest available commercial dose, get liver and kidney labs at 8 weeks alongside your hormone panel, and make a decision based on what you actually measure.
Medical disclaimer: This article is for educational purposes only. Fadogia agrestis is an unvalidated supplement with no established human safety profile. Do not use it without first consulting your doctor, particularly if you have liver or kidney conditions, take prescription medications, or have been diagnosed with any hormonal disorder.
FAQ
Does fadogia agrestis actually work in humans? No human randomized controlled trial has confirmed it. The evidence base consists of rat studies showing dose-dependent testosterone and LH increases. Whether those findings apply to humans at commercially available doses is unknown. Men should understand the distinction between animal data and human clinical evidence before purchasing.
How does fadogia agrestis compare to tongkat ali? Tongkat ali has multiple published human RCTs showing measurable testosterone effects. Fadogia agrestis has none. For men making evidence-based decisions, tongkat ali is the stronger choice in this category by a wide margin.
What is the safe dose of fadogia agrestis for men? No established safe dose exists for humans because no human pharmacokinetic or safety study has been published. Commercial products sell 400-600 mg/day extrapolated from rat data. The same rat studies show liver, kidney, and testicular toxicity signals at higher doses. A lower dose with lab monitoring is more defensible than standard commercial doses.
Can fadogia agrestis damage your testosterone long-term? Animal studies show testicular histological changes at higher doses, affecting the very cells that produce testosterone. Whether these findings translate to humans is unknown. The theoretical risk of impairing testosterone production by damaging Leydig cells is not negligible and warrants caution.
How long does fadogia agrestis take to work? In rat studies, measurable testosterone changes appeared within 5 days. No human timeline data exists. If you try it and see no change in labs after 8 weeks, continuing is not supported by evidence.
Is fadogia agrestis safe to stack with tongkat ali? Many commercial products combine the two. No human study has examined this combination. Since tongkat ali has human safety data and fadogia agrestis does not, the unknown is specifically fadogia's contribution to any observed effect and any interaction. Starting with tongkat ali alone and evaluating your response before adding an uncharacterized compound is a sounder approach.
Should I take fadogia agrestis if my testosterone is low? First confirm your testosterone is actually low with a blood test and understand the cause. The free testosterone calculator helps interpret your lab results. Then work through interventions with human evidence: correct zinc or vitamin D deficiency, reduce visceral fat, improve sleep. How to increase free testosterone naturally covers the full protocol. Fadogia agrestis belongs further down that list, not at the start.
What are the side effects of fadogia agrestis? No controlled human side effect data exists. Animal studies document dark urine in some rodent studies, elevated liver enzymes, kidney stress markers, and testicular structural changes at higher doses. In humans, the side effect profile is entirely unknown. This uncertainty is itself a reason for caution.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any new exercise, nutrition, or supplement program.